PharmaCann is a vertically integrated cannabis company that provides cannabis products. The company self-describes as one of the country's largest vertically integrated cannabis companies, providing safe, reliable, top-quality cannabis products.

PharmaCann

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

Curaleaf Holdings, Inc.

PharmaCann, founded in 2014, is one of the country’s largest vertically integrated cannabis companies, providing safe, reliable, top-quality cannabis products to improve people’s lives. By investing in people, practices and infrastructure, we are shaping a new, vital, wellness-focused industry. Our goal is to increase sustainable access to cannabis by offering effective, affordable and trusted products and services. 

We are licensed in eight states to grow, process and/or dispense medicinal cannabis products for adult and pediatric patients, as well as for responsible adult use. We are expanding rapidly but steadily as we continue to earn new state licenses and gain recognition as a trusted resource in this evolving space. 

We invest in best practices at every turn to ensure people have access to the most effective options for feeling and living better. We are constantly researching and developing new forms and formulations of cannabinoid-based treatments to improve people’s well-being and help them live their best lives.

PharmaCann Inc

This past Friday, in partnership with SESH & MATTIO Communications, we celebrated our brands; P3, LivWell, matter. & Magnitude finally available for Adult Use sales in New York.

Located in the heart of Manhattan, THC NYC in Soho, was the perfect place to enjoy our latest releases and connect with those in the NY Cannabis Community. 

We look forward to what is to come in the state of New York this year and beyond! 

Check out pharmacann.com/brands and reach out to wholesale@pharmacann.com with any sales inquiries.

Dive into the loyalty celebration with LivWell Loyalty Week March 11 - 17! It's our way of saying THANK YOU! 🌿 Learn more at livwell.com/sweepstakes

Shop Confidently with LivWell! We're now offering price match at all of our dispensaries! Learn more at LivWell.com/price-match 🌿

Verilife is now open in Silver Spring, MD!

Exciting news for the cannabis industry 🌿 The DEA's proposal to reclassify marijuana signals a significant shift in American drug policy, potentially opening doors for wider medical use.

We look for a public statement from the DEA following this news and further movement towards accomplishing rescheduling.

https://lnkd.in/edv9j3Km

Metric
Company Name	PharmaCann	Curaleaf Holdings, Inc.
Symbol		CURA
MSH ID	COM:PHARMACANN	COM:CURALEAF
Market	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare
Industry	Cannabis	Drug Manufacturers - Specialty & Generic
Country	US	US
Stage
Employee Count	643	5.65K
Website	pharmacann.com	curaleaf.com
LinkedIn	pharmacanninc
Founders

Metric
Market Cap		2.70B
Enterprise Value
Monthly Web Traffic		2.08M
Web Traffic Growth		-0.40
Valuation
Raised Capital

Metric
Revenue		1.82B
Revenue (LTM)
Revenue (NTM)
Gross Profit		644.70M
EBITDA		343.90M
Operating Income		57.88M
Net Income		-379.53M
EPS		-0.52
Diluted EPS		-0.52
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.38
Operating Profit Margin		0.04
EBITDA Margin		0.19
Net Profit Margin		-0.19
Return on Equity		-0.25
Return on Assets		-0.09
Return on Capital Employed		0.02

PHAR

COM:PHARMACANN

PharmaCann

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-6.35
P/B Ratio		1.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		1.37
EV Multiple		4.89

Metric
Days Sales Outstanding		18.73
Days Payables Outstanding		30.85
Days Inventory Outstanding		90.60
Operating Cycle		109.33
Cash Conversion Cycle		78.48
Asset Turnover		0.56

Metric
Operating Cash Flow		101.58M
Free Cash Flow		6.69M
Cash Flow to Debt		0.18
Operating Cash Flow/Sales		0.09
Free Cash Flow Yield		0.02

Metric
Cash & Equivalents		121.07M
Accounts Receivable		148.47K
Inventory		284.70M
Goodwill		826.27M
Debt to Capitalization		0.46
Debt to Assets		0.20
Current Ratio		0.72
Quick Ratio		0.50

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.01
R&D to Revenue
SG&A to Revenue		0.21